GENERIC NAME: DROPERIDOL INJECTION (dro-PAIR-id-all)
BRAND NAME(S): Inapsine
WARNING: Infrequent, but sometimes fatal heart problems (arrhythmias such as torsades) have occurred with droperidol use at or even below recommended doses. Droperidol use should be restricted to those in whom other drugs have failed to work well, or caused serious side effects. It should not be used in people with known or suspected heart problems (QTc prolongation). It should be used with caution in people at risk for QTc prolongation, such as those with heart failure, slow heart rate (bradycardia), heart enlargement (hypertrophy), low potassium or magnesium, alcoholics, or the elderly. Report to the doctor immediately symptoms such as severe dizziness, fainting, or irregular/rapid heartbeat. EKG testing should be performed before, during and for 2-3 hours after treatment with this drug. See also Drug Interactions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.